Open

Petosemtamab Drug Study

In this study, we want to see if a new drug called petosemtamab is effective. The study is for patients who have head and neck cancer that has spread or come back and cannot be cured. We want to see if petosemtamab works better than the treatments doctors usually use.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

During study visits you will receive study drug and relevant blood work, questionnaires and other testing will be done.

Incentives

Stipend of up to 75/visit.

In-person visits:
30

Phone or online visits:
6

Total length of participation:
24 months

Looking for Specific Volunteers

Able to participate:

You have incurable head and neck squamous cell
You have metastatic/recurrent head and neck squamous cell

Not eligible if:

You have any systemic anticancer therapy within 4 weeks of the first dose of study treatment
You have untreated or symptomatic central nervous system metastases, or require radiation, surgery, or continued steroid therapy to control symptoms within 14 days of study
Participation in an interventional clinical study with any investigational drug within 4 weeks prior to study entry, OR participation in any clinical study with petosemtamab

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Comprehensive Cancer center
Cancerclinicaltrials@med.unc.edu
(919) 966-4432

Primary Visit Location

Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Sid Sheth
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Head and Neck)

IRB Number

24-1875

ClinicalTrials.gov

NCT06496178

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.